To the Editor: Cleidocranial dysplasia (CCD; MIM119600) is an autosomal dominant disease characterized by multiple skeletal abnormalities, dental anomalies and hearing impairment (HI) (1, 2). CCD is caused by mutations in the CBFA1 gene (corebinding factor a1) (2, 3) encoding a transcription factor that activates osteoblast differentiation (4). CBFA1 contains three major domains: Q/A domain, runt domain and PST domain (3, 5–7). A majority of the mutations detected in patients with CCD affect the runt domain or the Q/A domain (8–13). The aim of our study was to assess the clinical features and genetic background of Polish patients with CCD. A total of 12 patients with a clinical diagnosis of CCD (2) were studied (3 from a single family – Fig. 1 – and 9 sporadic cases). The studied cohort included six boys and six girls; the average age was 8.2 years (range 4–13 years). The molecular analysis was performed on seven patients (one familial and six sporadic cases, whereas three remaining patients refused to participate). Exons 1–3 of CBFA1 (encoding Q/A and runt domains) were amplified by PCR and sequenced. Primers were designed by Primer 3 software (14). Sequence positions are according to the GenBank entries AF001443 to AF001450, with the A in the start codon ATG and the initiator Methionine numbered as the first base pair and amino acid residue, respectively. For the statistical analysis, Fisher’s exact test was used. All patients displayed delayed closure of fontanels and sutures and hypoplastic/aplastic clavicles. Supernumerary teeth were found in six out of eight examined subjects. Other relatively constant abnormalities were short stature (less than fifth percentile) in 11/12 (92%), facial dysmorphism (midfacial hypoplasia and hypertelorism) in 10/12 (83%), highly arched palate in 9/12 (75%), Wormian bones in 10/12 (83%), pelvis anomalies (hypoplastic iliac wings and/or hypoplastic/aplastic pubic bones) in 10/12 (83%), and coxa vara/valga in 5/12 (42%). In seven patients, audiological examination was performed revealing HI in four cases (conductive HI in three patients and mixed HI in one). In summary, we found in our patients the typical clinical features of CCD as described previously (1, 15). An interesting observation is that all patients with HI had also chronic otitis media. This finding emphasizes the role of chronic otitis media in the pathogenesis of HI in CCD (16). Another interesting observation is a history of laryngotracheomalacia in one patient. To our knowledge, this complication has not yet been reported in CCD. However, since CBFA1 is involved not only in bone formation but also in regulation of chondrocyte differentiation (2), it is possible that this manifestation was also related to CCD. Mutations in the sequenced region of CBFA1 were found in four subjects: the p.R193X (c.577C.T) mutation (10) in three sporadic cases and the p.R190W (c.568C.T) mutation (17) in one sporadic case. The patient with the p.R190W
[1]
M. Redlich,et al.
Cleidocranial dysplasia: Molecular genetic analysis and phenotypic‐based description of a Middle European patient group
,
2005,
American journal of medical genetics. Part A.
[2]
Brendan H. Lee,et al.
Mutations and promoter SNPs in RUNX2, a transcriptional regulator of bone formation.
,
2005,
Molecular genetics and metabolism.
[3]
A. Lalwani,et al.
Otolaryngological Manifestations of Cleidocranial Dysplasia, Concentrating on Audiological Findings
,
2003,
The Laryngoscope.
[4]
M. Digilio,et al.
Six novel mutations of the RUNX2 gene in Italian patients with cleidocranial dysplasia
,
2003,
Human mutation.
[5]
H. Kanegane,et al.
Functional analysis of RUNX2 mutations in cleidocranial dysplasia: novel insights into genotype-phenotype correlations.
,
2003,
Blood cells, molecules & diseases.
[6]
Brendan H. Lee,et al.
A natural history of cleidocranial dysplasia.
,
2001,
American journal of medical genetics.
[7]
A. Giannotti,et al.
A novel CBFA1 mutation (R190W) in an Italian family with cleidocranial dysplasia
,
2000,
Human Mutation.
[8]
Lei Zhou,et al.
CBFA1 mutation analysis and functional correlation with phenotypic variability in cleidocranial dysplasia.
,
1999,
Human molecular genetics.
[9]
S. Mundlos,et al.
Mutation analysis of core binding factor A1 in patients with cleidocranial dysplasia.
,
1999,
American journal of human genetics.
[10]
S. Mundlos.
Cleidocranial dysplasia: clinical and molecular genetics
,
1999,
Journal of medical genetics.
[11]
A. Baldini,et al.
Missense mutations abolishing DNA binding of the osteoblast-specific transcription factor OSF2/CBFA1 in cleidocranial dysplasia
,
1997,
Nature Genetics.
[12]
M. Owen,et al.
Mutations Involving the Transcription Factor CBFA1 Cause Cleidocranial Dysplasia
,
1997,
Cell.
[13]
G. Karsenty,et al.
Osf2/Cbfa1: A Transcriptional Activator of Osteoblast Differentiation
,
1997,
Cell.
[14]
M. Ohki,et al.
The Runt domain identifies a new family of heteromeric transcriptional regulators.
,
1993,
Trends in genetics : TIG.
[15]
S Rozen,et al.
Primer3 on the WWW for general users and for biologist programmers.
,
2000,
Methods in molecular biology.
[16]
B. L. Jensen,et al.
Somatic development in cleidocranial dysplasia.
,
1990,
American journal of medical genetics.